Tert-butyl 3-oxopiperazine-1-carboxylate → 4-[3-(1-Tert-butoxycarbonyl-piperidin-4-yl)-propyl]-3-oxo-piperazine-1-carboxylic acid benzyl ester
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][NH:11][C:10](=[O:14])[CH2:9]1)=[O:7])([CH3:4])(C)C.[C:15]([O:19][C:20]([N:22]1[CH2:27][CH2:26][CH:25]([CH2:28][CH2:29][CH2:30]Br)[CH2:24][CH2:23]1)=[O:21])([CH3:18])([CH3:17])[CH3:16].BrC[C:34]1[CH:43]=[C:42]2C(C(Cl)=NC=N2)=[CH:36][CH:35]=1>>[CH2:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][N:11]([CH2:30][CH2:29][CH2:28][CH:25]2[CH2:26][CH2:27][N:22]([C:20]([O:19][C:15]([CH3:18])([CH3:17])[CH3:16])=[O:21])[CH2:23][CH2:24]2)[C:10](=[O:14])[CH2:9]1)=[O:7])[C:4]1[CH:42]=[CH:43][CH:34]=[CH:35][CH:36]=1Participants
4
Procedure
The title compound is prepared as described in EXAMPLE 72, Part A, substituting 3-oxopiperazine-1-carboxylic acid benzyl ester for 3-oxopiperazine-1-carboxylic acid tert-butyl ester and 4-(3-bromopropyl)-piperidine-1-carboxylic acid tert-butyl ester for 7-bromomethyl-4-chloroquinazoline. The title compound is obtained as a white foam. 1H NMR (CDCl3, 300 MHz) δ7.38 (m, 5H), 5.12 (s, 2H), 4.18 (m, 4H), 3.73 (m, 2H), 3.33 (m, 4H), 2.66 (m, 2H), 1.58 (m, 6H), 1.42 (s, 9H), 1.38 (m, 3H).
Workup
- customThe title compound is prepared
Sources & evidence
- ORD record
- ord-723f3f49ff624205999200b825f26884
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07612075B2
Reaction notes
Loading…